Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Cancer Research

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 12060622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long‐term survival in Japanese patients with breast cancer

  2004cited by this paper
• Clinical significance of angiogenic factors in breast cancer

  2004cited by this paper
• Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma — results of a multiparametric study

  2004cited by this paper
• Expert Commentary.

  2002cited by this paper
• Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

  2001cited by this paper
• The role of HER2 in angiogenesis.

  2001cited by this paper
• The effect of tamoxifen on breast tumour vascularity

  2001cited by this paper
• Bcl‐2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line

  2000cited by this paper
• Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models.

  2000cited by this paper
• Prognostic value of vascular endothelial growth factor in breast cancer.

  2000cited by this paper
• Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

  2000cited by this paper
• p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.

  2000influential reference
• More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

  2000cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma

  1999influential reference
• Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.

  1999influential reference
• Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients.

  1998cited by this paper
• Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

  1997cited by this paper
• Effects of tamoxifen and interferon‐β or the combination on tumor‐induced angiogenesis

  1997cited by this paper
• The microtubule-affecting drug paclitaxel has antiangiogenic activity.

  1996cited by this paper
• Prognostic significance of microvessel density in lymph node negative breast carcinoma.

  1995cited by this paper
• Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?

  1995cited by this paper
• Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

  1995cited by this paper
• Statistica for Windows

  1995cited by this paper
• Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.

  1995cited by this paper
• Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.

  1995cited by this paper
• Microvessel density and vessel invasion in lymph‐node‐negative breast cancer: Effect on recurrence‐free survival

  1995cited by this paper
• Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

  1994cited by this paper
• Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.

  1994cited by this paper
• Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

  1994cited by this paper
• p53 as an independent prognostic marker in lymph node-negative breast cancer patients.

  1993cited by this paper
• Inhibition of angiogenesis by antiestrogens.

  1993cited by this paper
• Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer.

  1993cited by this paper
• Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

  1993cited by this paper
• Microvessel quantitation and prognosis in invasive breast carcinoma.

  1992cited by this paper
• Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

  1992cited by this paper
• Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up.

  1992cited by this paper
• Is the relationship between angiogenesis and metastasis in breast cancer real?

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Estrogen receptor analyses in breast cancer: comparison of monoclonal immunohistochemical and biochemical methods.

  1989cited by this paper
• How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

  1986cited by this paper
• Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

  1985cited by this paper
• WHO Handbook for Reporting Results of Cancer Treatment

  1982cited by this paper
• WHO Handbook for Reporting Results of Cancer Treatment

  1980cited by this paper

• Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model

  2021cites this paper
• cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer

  2018cites this paper
• Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma

  2017cites this paper
• Genotyping of Human Papilloma Virus (HPV) Isolated from Breast Cancer Patients in Radiation and Isotopes Center Khartoum (RICK)–Sudan

  2017cites this paper
• Asses microvascular densities in breast ductal cell carcinoma (using CD 31 & VWF immunostain), in correlation to ER status

  2017cites this paper
• Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane

  2017cites this paper
• An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast Tumors

  2016cites this paper
• Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma

  2016cites this paper
• Absence of CD66a expression is associated with high microvessel density and high histologic grade in hepatocellular carcinoma

  2016cites this paper
• The association between expressions of Ras and CD68 in the angiogenesis of breast cancers

  2015cites this paper
• Initial characterization of tumor heterogeneity in a syngeneic breast cancer model

  2015cites this paper
• Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis

  2015cites this paper
• Marzieh Bahador Initial characterization of tumor heterogeneity in a syngeneic breast cancer model

  2015cites this paper
• Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast.

  2014cites this paper
• Changes of oral microcirculation in chemotherapy patients: A possible correlation with mucositis?

  2014cites this paper
• Correlation of Tumor-Infiltrative Lymphocyte Subtypes Alteration with Neoangiogenesis before and after Neoadjuvant Chemotherapy Treatment in Breast Cancer Patients

  2014cites this paper
• Magnetic fluid hyperthermia inhibits the growth of breast carcinoma and downregulates vascular endothelial growth factor expression

  2014cites this paper
• Cytoreductive Chemotherapy Improves the Biodistribution of Antibodies Directed against Tumor Necrosis in Murine Solid Tumor Models

  2013cites this paper
• Quantitative Analysis of Photodynamic Therapy Effects in Rat Mammary Tumor Vascular Density Using Image-Pro plus Software

  2013cites this paper
• Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib

  2012cites this paper
• Effects of estrogen depletion on angiogenesis in

  2012cites this paper
• Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy

  2012cites this paper
• Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma – an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy

  2012cites this paper
• Prädiktiver Wert und Verlaufsbeobachtung der Tumorvaskularisierung in der primär systemischen Therapie des Mammakarzinoms

  2011cites this paper
• A potential role of alpha-7 nicotinic acetylcholine receptor in cardiac angiogenesis in a pressure-overload rat model.

  2010cites this paper
• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients

  2010cites this paper
• QUANTIFICATION OF MEAN VESSEL DENSITY IN RETINOBLASTOMA AND ITS CORRELATION WITH LOCAL TUMOR INVASION AND PATIENTS SURVIVAL

  2010cites this paper
• Comparison of three vascular endothelial markers in the evaluation of microvessel density in breast cancer.

  2009cites this paper
• The acute effects of CMF-based chemotherapy on maxillary periodontal microcirculation

  2009cites this paper
• Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors

  2009cites this paper
• Endpoints for the Determination of Efficacy of Antiangiogenic Agents in Clinical Trials

  2008cites this paper
• Efecto de la quimioterapia neoadyuvante con antraciclinas en la angiogenia del cáncer de mama

  2008cites this paper
• [Evolution of angiogenesis following anthracycline-based neoadjuvant chemotherapy in breast cancer].

  2008cites this paper
• Inflammatory Breast Cancer as a Model Disease to Study Tumor Angiogenesis: Results of a Phase IB Trial of Combination SU5416 and Doxorubicin

  2007cites this paper
• International Seminars in Surgical Oncology Quantification of Angiogenesis in Estrogen Receptor-positive and Negative Breast Carcinoma

  2007cites this paper
• Efeitos do raloxifeno sobre a angiogênese do carcinoma de mama de mulheres menopausadas

  2007cites this paper
• Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer.

  2007influential citation
• Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy

  2007cites this paper
• Histopathologic assessment of hot‐spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors

  2006cites this paper
• A pilot study with long term follow up of hyperbaric oxygen pretreatment in patients with locally advanced breast cancer undergoing neo-adjuvant chemotherapy.

  2006cites this paper
• The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer

  2006cites this paper
• Neovascularization and Neoinnervation of Subcutaneously Placed Nucleus Pulposus and the Inhibitory Effects of Certain Drugs

  2005cites this paper
• Microvascular density of breast cancer in bone metastasis: influence of therapy.

  2005cites this paper
• Novel Phase I Dose De-escalation Design Trial to Determine the Biological Modulatory Dose of the Antiangiogenic Agent SU5416

  2005cites this paper
• The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.

  2005cites this paper
• Evaluation of Novel Agents Which Target Neovasculature of Breast Tumors

  2005cites this paper
• Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.

  2004cites this paper
• Assessment of microvessel density in core needle biopsy specimen in breast cancer.

  2004cites this paper
• Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives

  2004cites this paper
• The morphological analysis of vasculature in thyroid tumours: immunoexpression of CD34 antigen.

  2004cites this paper
• Histological quantitation of tumour angiogenesis

  2004cites this paper
• Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma

  2004cites this paper
• Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

  2003influential citation
• Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies

  2003cites this paper
• Functional Relationship and Gene Ontology Classification of Breast Cancer Biomarkers

  2003cites this paper
• Functional relationship and gene ontology classification of breast cancer biomarkers.

  2003cites this paper